CATEGORIES
Govt opens institute for science communication & policy research
The government has opened a new institute of Council of Scientific and Industrial Research (CSIR) i.e. CSIR-National Institute of Science Communication and Policy Research (CSIR-NIScPR), in New Delhi.
9 Trends Of New Post-Covid Era
As the world wakes up to the new post-COVID reality, the vaccine industry is entering a new paradigm that is one in which vaccines are perceived as effective medical interventions, which will have wider acceptance in the society, and which need to be supported.
WHO announces updates on systematic screening for TB
World Health Organization (WHO) has announced a number of updates to its forthcoming guidance on the systematic screening of tuberculosis (TB) disease.
INDIAN BIOPHARMA HITS RS 25,000 CRORE RIDING 15% GROWTH WAVE
The Indian Biopharma Industry, with over 300 companies, is growing at the rate of 15 per cent, which is 3 per cent more than the previous year’s 12 per cent.
Piramal Pharma invests $32M to expand API facility in US
Mumbai based Piramal Pharma Limited’s Pharma Solutions business, a leading contract development and manufacturing organization (CDMO), has announced plans to expand its facility in Michigan in the US with additional capacity and new capabilities for the development and manufacturing of Active Pharmaceutical Ingredients (APIs).
Govt launches SARS-CoV-2 genomic consortium to monitor viral mutations
The government has launched the Indian SARS-CoV-2 Genomic Consortia (INSACOG), comprising 10 labs namely DBT-NIBMG Kalyani, DBT-ILS Bhubaneswar, ICMRNIV Pune, DBT-NCCS Pune, CSIR-CCMB Hyderabad, DBT-CDFD Hyderabad, DBT-InSTEM/ NCBS Bengaluru, NIMHANS Bengaluru, CSIR-IGIB Delhi, and NCDC Delhi.
Korea conducts typhoid vaccine study in Nepal
Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK Bioscience based in South Korea, has met the primary endpoints in a Pase III study in Nepal.
Govt works towards AYUSH export promotion council
The Ministry of Commerce and Industry and the Ministry of AYUSH have decided to work together to set up an Export Promotion Council to boost AYUSH exports.
GAVI nominates Dr Harsh Vardhan as India representative
Dr Harsh Vardhan, Union Minister, Health and Family Welfare has been nominated by the Global Alliance for Vaccines and Immunisation (GAVI) as a member of the GAVI Board. He will be representing the South-East Area Regional Office (SEARO)/ Western Pacific Regional Office (WPRO) constituency on the GAVI Board from January 1, 2021 until December 31, 2023.
BARC develops indigenous Ruthenium 106 plaque to treat eye cancer
Dr Jitendra Singh, Union Minister of State (Independent Charge) Development of North Eastern Region (DoNER), MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space has lauded the Bhabha Atomic Research Centre (BARC) in Mumbai for developing eye cancer therapy in the form of the first indigenous Ruthenium 106 plaque for treatment of ocular tumours.
CSIR reveals anti-viral benefits of chlorhexidine mouthwash
A preliminary laboratory based research conducted by researchers at Panjab University in collaboration with CSIR-Institute of Microbial Technology (IMTECH) has revealed that one of the most routinely used mouth rinses, Chlorhexidine, has proven to be effective against SARS-CoV-2.
Health Ministry Unveils Website On Repurposed Drugs For Covid-19
The Ministry of Health and Family Welfare has launched a website that gives comprehensive information about the numerous COVID-19 clinical trials that Council of Scientific and Industrial Research (CSIR) is engaged in partnership with industry, other government departments and ministries.
World Bank approves $12B for COVID-19 vaccine support
The World Bank’s Board of Executive Directors has approved an envelope of $12 billion for developing countries to finance the purchase and distribution of COVID-19 vaccines, tests, and treatments for their citizens.
WHO issues alerts on falsified medical products
The World Health Organisation (WHO) has issued an alert for medical product related to three different batches of confirmed falsified Fluzone Quadrivalent Influenza Vaccine identified in Mexico and reported to WHO.
Pakistan emphasizes on breast cancer awareness
The Quaid-i-Azam University (QAU) has signed a Memorandum of Understanding (MoU) with Pink Pakistan Trust with an aim to spread awareness on breast cancer and its early detection within Pakistan.
Siemens Healthineers to invest Rs 1300 Cr in innovation hub
To advance the digitalization of healthcare and better serve the needs of emerging markets, Siemens Healthineers has announced plans to invest Rs 1300 crore over the next five years in an innovation hub in Bengaluru.
Supporting innovation in 2021
COVID-19 is likely to impact India’s economy across all industries and business formats. Nevertheless, the biosuppliers sector is gearing up to adopt the new normal and is all set to launch new products in next 12 months in 2021. The upcoming products are spread across a wide range of applications for the life sciences industry such as cell imaging, sample analysis, nanotechnology, gene sequencing, microbiology research, microencapsulation and much more.
IIT-Kgp develops economical device for COVID-19 testing
Covirap, the diagnostic machine developed by the Indian Institute of Technology, Kharagpur (IIT-Kgp) researchers, has been successfully validated for its efficacy in COVID-19 detection by the Indian Council of Medical Research (ICMR).
Medtech startup EzeRx gathers Rs 1.75 Cr in seed round
Medtech startup EzeRx from Kolkata has secured Rs 1.75 crore in a seed funding round backed by the Odisha based KIIT Technology Business Incubator (TBI).
IISER-Pune focuses on checking asymptomatic COVID-19 cases
Researchers from the Indian Institute of Science Education and Research IISER) in Pune, along with the BJ Medical College in Ahmedabad have developed a fast and sensitive device that can help detect asymptomatic COVID-19 patients by testing their sense of smell.
IIHMR, John Hopkins initiate vaccine economics course
With COVID-19 dramatically altering vaccine decision making globally, the world is faced with new challenges on how to maintain routine vaccine coverage and plan the rapid deployment of a coming COVID-19 vaccine.
WHO Pushes Availability Of Covid-19 Rapid Tests For LMICs
A set of agreements to make available, for low and middle-income countries (LMICs), affordable, high-quality COVID-19 antigen rapid tests have been announced by the Access to COVID-19 Tools (ACT) Accelerator.
Is COVID-19 Sidelining NCDs?
The pandemic has affected the supervision of non-communicable diseases (NCDs) not only in terms of overshadowing their severity and hazards but also in prioritization of their therapeutic consideration. Although a number of initiatives are being carried out by the industry and government to address this, there is also the urgent need to build a national strategic framework for managing NCDs during a pandemic.
“We have 18 international patents granted for Stempeucel pooling technology”
Bengaluru based Stempeutics Research has received regulatory approval from the Drug Controller General of India (DCGI) for the launch of Stempeucel in India.
Virtual Clinical Trials – An approach whose time has come
The COVID-19 pandemic will surely go down as a major event of the century and an event that will leave a long-lasting impression on our way of living and working.
REGULATE MEDICAL AESTHETICS
The market that is worth billions of dollars in India has witnessed significant growth in the demand for aesthetic procedures owing to the rise in the number of doctors and surgeons providing effective medical aesthetic treatments and the launch of technologically advanced products for the same. However, India lacks proper guidelines to regulate the use of specific products and procedures for aesthetic treatment.
IIT-M makes nano-coated Mg alloys to fix bone fractures
Indian Institute of Technology, Madras (IIT-M) researchers have developed nano-coated magnesium (Mg) alloys that can repair bone defects in rabbits.
IIT-D partners with ILBS for enhancing medical research
(IIT-D) and (ILBS), Delhi has signed a Memorandum of Understanding (MoU)
Dr Reddy's Laboratories to supply 100 M doses of Sputnik V vaccine to India
Supply to Dr Reddy’s 100 Million Doses of The Vaccine.
Hester Bio acquires Brucella vaccine technology from IVRI
Agreement Hester Biosciences has signed